mavacamten 5 MG Oral Capsule

RxCUI
2600888
RxNorm name
mavacamten 5 MG Oral Capsule
Display name
mavacamten 5 MG Oral Capsule
Full name
mavacamten 5 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CAMZYOSMAVACAMTENMyokardia, Inc.669c936b-3ee6-4e36-8a22-79dd11b1255b2025-04-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2600888

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
669c936b-3ee6-4e36-8a22-79dd11b1255bmavacamten 5 MG Oral Capsule [PSN] · mavacamten 5 MG Oral Capsule [SCD]28These highlights do not include all the information needed to use CAMZYOS safely and effectively. See full prescribing information for CAMZYOS. CAMZYOS ® (mavacamten) capsules for oral use Initial U.S. Approval: 202220250417